Regular Article
Modulating Excitatory Synaptic Neurotransmission: Potential Treatment for Neurological Disease?

https://doi.org/10.1006/nbdi.1998.0190Get rights and content

Abstract

Excitatory neurotransmission at many CNS synapses depends upon AMPA-type glutamate receptors. Derangements in AMPA receptor-mediated synaptic transmission may be a contributing factor in neurological and neurodegenerative diseases and could be a target for therapeutic intervention. Drugs that positively modulate AMPA receptors by reducing AMPA receptor desensitization and/or slowing AMPA receptor deactivation, such as thiazide derivatives (cyclothiazide, diazoxide, IDRA 21) and benzoylpiperidine derivatives (1-BCP, CX516, aniracetam), facilitate AMPA receptor-mediated processes and may have beneficial therapeutic effects. For example, AMPA modulators facilitate long-term potentiation, which may be important for memory storage, and facilitate memory encoding in behavioral experiments. Thus, AMPA modulators might ameliorate memory deficits that occur in dementia, such as Alzheimer's disease. However, AMPA receptor-mediated excitotoxicity may occur with excessive AMPA receptor activation such as in seizures or ischemia, and positive AMPA modulators would promote neuronal injury under those conditions. Regardless of the ultimate clinical utility of positive AMPA modulators, their discovery and study have already provided significant insight into the physiology and structural determinants of important AMPA receptor properties. This review attempts to synthesize a variety of studies that have utilized these AMPA modulators to gain insight into fundamental as well as clinically relevant AMPA receptor-mediated processes.

References (85)

  • M. Hollmann et al.

    N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1

    Neuron

    (1994)
  • J.E. Huettner

    Glutamate receptor channels in rat DRG neurons: Activation by kainate and quisqualate and blockade of desensitization by con A

    Neuron

    (1990)
  • M. Ingvar et al.

    Enhancement by an ampakine of memory encoding in humans

    Exp. Neurol.

    (1997)
  • N.I. Kiskin et al.

    Excitatory amino acid receptors in hippocampal neurons: Kainate fails to desensitize them

    Neurosci. Lett.

    (1986)
  • G. Lynch et al.

    Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans

    Exp. Neurol.

    (1997)
  • P.C. May et al.

    GYKI 52466 protects against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures

    Neurosci. Lett.

    (1993)
  • A.M. Moudy et al.

    Rapid desensitization determines the pharmacology of glutamate neurotoxicity

    Neuropharmacology

    (1994)
  • K.M. Partin et al.

    Structural determinants of allosteric regulation in alternatively spliced AMPA receptors

    Neuron

    (1995)
  • K.M. Partin et al.

    Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavilin A

    Neuron

    (1993)
  • A.V. Paternain et al.

    Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons

    Neuron

    (1995)
  • D.E. Pellegrini-Giampietro et al.

    The GluR2 (GluR-B) hypothesis: Ca2+

    Trends. Neurosci.

    (1997)
  • L.O. Trussell et al.

    Glutamate receptor desensitization and its role in synaptic transmission

    Neuron

    (1989)
  • L.O. Trussell et al.

    Desensitization of AMPA receptors upon multiquantal neurotransmitter release

    Neuron

    (1993)
  • J.Z. Tsien et al.

    The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory

    Cell

    (1996)
  • D.P. Uzunov et al.

    Enantiomeric resolution with a new chiral stationary phase of 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazineS,S

    J. Pharm. Sci.

    (1995)
  • L. Vyklicky et al.

    Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/Kainate receptors

    Neuron

    (1991)
  • K.A. Yamada

    AMPA receptor activation potentiated by the AMPA modulator 1-BCP is toxic to cultured hippocampal neurons

    Neurosci. Lett.

    (1998)
  • C.F. Zorumski et al.

    Properties of vertebrate glutamate receptors: Calcium mobilization and desensitization

    Prog. Neurobiol.

    (1992)
  • C.F. Zorumski et al.

    A benzodiazepine recognition site associated with the non-NMDA glutamate receptor

    Neuron

    (1993)
  • A. Arai et al.

    Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices

    Neuroreport

    (1996)
  • M.C. Bateman et al.

    AMPA receptor desensitization in hypoxic neuronal injury in vitro

    Neurology

    (1993)
  • M. Bertolino et al.

    Modulation of AMPA/Kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus

    Receptors Channels

    (1993)
  • T.V. Bliss et al.

    A synaptic model of memory: Long-term potentiation in the hippocampus

    Nature

    (1993)
  • T.V. Bliss et al.

    Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path

    J. Physiol.

    (1973)
  • J. Boulter et al.

    Molecular cloning and functional expression of glutamate receptor subunit genes

    Science

    (1990)
  • J.D. Clements et al.

    The time course of glutamate in the synaptic cleft

    Science

    (1992)
  • D. Colquhoun et al.

    Action of brief pulses of glutamate on AMPA/KA receptors in patches from different neurones of rat hippocampal slices

    J. Physiol.

    (1992)
  • J.C. David et al.

    AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked

    J. Neurosci.

    (1996)
  • J. Egebjerg et al.

    Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA

    Nature

    (1991)
  • M.W. Fleck et al.

    AMPA receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to cyclothiazide

    J. Neurophysiol.

    (1996)
  • J.A. Gorter et al.

    Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+

    J. Neurosci.

    (1997)
  • R. Granger et al.

    A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task

    Synapse

    (1993)
  • Cited by (75)

    • Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant

      2023, Neuropharmacology
      Citation Excerpt :

      The combination of flip and flop splice variants, RNA editing, and changes in the number and subtype of receptor subunits provides a wide range of diversity and flexibility in the construction of AMPA-Rs. AMPA-R agonists, which can non-selectively activate resting AMPA-Rs, have been shown to induce AMPA-R desensitization and seizures (Beattie et al., 2000; Ehlers, 2000; Shaffer et al., 2013; Yamada, 1998). Thus, AMPA-R potentiators can have better pharmacological profiles with the selective promotion of physiological AMPA-R activation.

    • TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats

      2021, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Thus, AMPAR could be a promising drug target for the treatment of TRD. AMPAR activators—including AMPAR agonists and AMPAR potentiators—have some limitations such as insufficient potency, the risk of seizure, and bell-shaped dose–response (Bai et al., 2003; Beattie et al., 2000; Bernard et al., 2010; Ehlers, 2000; Fowler et al., 2004; Yamada, 1998). For example, several AMPAR potentiators, such as CX516, CX691, CX717, Org26576, LY451395, S18986, and S47445, have been clinically evaluated for neuropsychiatric indications, including cognitive impairment associated with Alzheimer's disease or schizophrenia, depressive symptoms, and attention-deficit/hyperactivity disorder (Kadriu et al., 2021).

    • Mechanisms of zinc modulation of olfactory bulb AMPA receptors

      2019, Neuroscience
      Citation Excerpt :

      However, in the 16 cells with AMPAR-mediated currents inhibited by 1 mM zinc, there was no significant correlation between the degree of inhibition and the S:P ratio (N = 16; Pearson's r = − 0.05413, P = 0.8422) (Fig. 3B). Cyclothiazide (CTZ) is a drug that inhibits AMPAR desensitization (Yamada and Tang, 1993; Yamada, 1998). Yamada and Tang (1993) reported that CTZ (0.3–100 μM) reduced desensitization of whole-cell currents activated by quisqualate in a concentration-dependent manner (Yamada and Tang, 1993).

    View all citing articles on Scopus

    M. G. PalfreymanI. J. ReynoldsP. Skolnick

    f1

    E-mail: [email protected]

    View full text